Drug Interruptions
tumor
REGRESSION, TUMOR, DISEASE
Drug interruptions occurred in 9 patients (Plot of confirmed tumor regression from baseline as measured by RECIST in all evaluable patients (Waterfall plot of disease response).Duration of treatment with avelumab and cabozantinib in all 3 cohorts with objective responses (Swimmer plot of disease response and treatment duration).Kaplan-Meier estimates of progression-free survival (PFS) for the overall study population.